<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The few cases of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> that have been reported in neonates are believed to have resulted from a transplacental transfer of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report on a boy with a neonatal <z:hpo ids='HP_0001297'>stroke</z:hpo> revealing a de novo primary antiphospholipid, the mother being free of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Other <z:mp ids='MP_0005048'>thrombosis</z:mp> risk factors included primiparity, <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo>, <z:hpo ids='HP_0001520'>macrosomia</z:hpo>, polyglobulia, and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) &gt;30 mg/dL </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> and anti-β(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I persisted more than 2 years </plain></SENT>
<SENT sid="4" pm="."><plain>Under aspirin therapy, the child did not exhibit recurrence of thrombotic events or symptoms of <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> after a follow-up of 3 years </plain></SENT>
<SENT sid="5" pm="."><plain>Our case indicates that clinicians should consider a second retesting for anticardiolipin antibodies and anti-β(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies, even when children and mother neonatal tests are negative </plain></SENT>
</text></document>